All posts by medical

Global Automatic Biochemistry Analyzers Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 – 3rd…

Global Automatic Biochemistry Analyzers Market Growth 2020-2025 combines the essentials, definitions, categorization, and analysis of significant features about the market. The report covers global market top players, types, applications, patterns, and size. The vital information featured in this report makes the research document a handy resource along with in the form of graphs and figures. The research analyzes various market dynamics, the quickest, and the slowest market segments. This document has all the useful essential information, for example, the financial strategies, applications, future growth, development, and advancement components of the global Automatic Biochemistry Analyzers market.

The comprehensive data comprises analysis on size and patterns, inhibitors, elements, drivers, openings and difficulties, condition and arrangement, cost outline, porters five power investigation, and key organizations profiles including business review and improvement. Data pertaining to the companys product range, product features, and individual product applications have been accentuated in the global Automatic Biochemistry Analyzers report. In addition, information regarding the growth prospects for the market in every specified region is also highlighted in the report.

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Automatic Biochemistry Analyzers market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/137014

Competitive Rivalry:

The report company profiles study the various companies operating in the global Automatic Biochemistry Analyzers market. It evaluates the financial outlooks of these companies, their research and development statuses, and their expansion strategies for the coming years. Key companies operating in the market are taking efforts to deliver upgraded products in the market and they are engaged in research activities, innovations, product developments, and technology adoptions. The report studies their strategic efforts such as mergers, acquisitions, ventures, and amalgamations.

The report demonstrates all the important data related to the prominent players covering Roche, Horiba Medical, Danaher, Abbott, Hitachi, Siemens Healthcare, KHB, Mindray Medical, Abaxis, Thermo Scientific, Urit, Randox Laboratories, Tecom Science, ELITech, Senlo, Sunostik, Adaltis, Sysmex, Gaomi Caihong, Dirui, Rayto, .

Consumption, production, capacity, market share, growth rate, and prices are included for each product type segment of global Automatic Biochemistry Analyzers market: Floor-standing, Bench-top,

Consumption, market share and growth rate for each application segment of Automatic Biochemistry Analyzers market: Primary Hospital, Provincial Hospital, Prefectural Hospital,

On the basis of the region, the market has been analyzed in Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries) along with its regional development status.

Moreover, in the global Automatic Biochemistry Analyzers market report, each regional market is extensively studied on the basis of import and export, key players, revenue, and production. This study document will help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in the industry.

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/137014/global-automatic-biochemistry-analyzers-market-growth-2020-2025

Aim Of The Automatic Biochemistry Analyzers Market Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketandresearch.biz

Read the rest here:
Global Automatic Biochemistry Analyzers Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 - 3rd...

COVID-19 Impact on Global Biochemistry Analyzer Industry 2020: Industry Trends, Size, Applications, SWOT Analysis by Top Key Players and Forecast…

Biochemistry Analyzer IndustryReport is designed to provide Industry Experts and Investors with detail overview of Biochemistry Analyzer Industry report, which will help them to take decisions with respect to Key Players, Regions, Manufacturers, Types and Trend etc.

This report gives a detail insight for a period of 2018-2025 Research Report. The market size estimations have been provided in terms of value (USD million).

Get Sample Copy of this Report at https://www.orianresearch.com/request-sample/590363

TheGlobal Biochemistry Analyzer Marketis expected to grow USD XX Million by 2025 at a CAGR of around 5.9% during the forecast period, 2018-2025. Biochemistry analyser can chemicals in biological samples. These analyzers focuses on analytes such as electrolytes, drugs of abuse, specific proteins, enzyme, and metabolite tests for cardiac, liver, and renal function.

Top Key Players Analyzed in Global Biochemistry Analyzer Market are Siemens AG Thermo Fisher Scientific, Inc. Randox Laboratories Ltd. Abbott, Danaher Corporation F.Hoffman-La Roche Ltd. Meril, Hologic Inc. Beckman Coulter Inc. Horiba Medical

The market size estimations have been provided in terms of value (USD million). The global Biochemistry Analyzer industry report also identifies major market players and provides analysis in terms of company overview, Financials, products & services, market trends, recent developments and growth strategies.

Regionally, North America, Latin America, Europe, Asia Pacific, And the Middle East & Africa constitute the key market segments.

Complete report on Biochemistry Analyzer Industry spread across 121 pages, profiling 8 companies and supported with tables and figures. For more details Enquire @https://www.orianresearch.com/enquiry-before-buying/590363

Theglobal Biochemistry Analyzer marketis anticipated to show significant growth during the forecast period. This growth can be attributed to rising incidence of diseases and rapidly growing demand for diagnostic tests. Due to a increase in the disposable income, the number of people with insurance has also increased, giving them accessibility to private labs that have high-end diagnostic instruments. However, high cost of diagnostic tests is key factor projected to curb the market growth over the forecast period.

Biochemistry analyzer have wide applications in Clinical Diagnostics, Drug Development Applications, Bioreactor By Product Detection and Others. clinical diagnostics segment was the leading segment and it accounted for largest share of total revenue generated in 2017. The drug development applications segment is forecast to be the second most lucrative segment in the global biochemistry analyzers market

Key Benefit Of This Report: Global, Regional, Country, Application, and TECHNOLOGY Market Size and Forecast from 2014-2025 Provide attractive market segments and associated growth opportunities Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies Identification of key companies that can influence this market on a global and regional scale Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies Detailed insights on emerging regions, product & application, and competitive landscape with qualitative and quantitative information and facts

Get Direct Copy of this Report @https://www.orianresearch.com/checkout/590363

In terms of revene, North America held large chunk of market share in 2017 on account of presence of developed healthcare infrastructure. In 2017, Europe was the second largest regional market in terms of revenue. Asia pacific is expected to witness rapid growth within the forecast period owing to increasing demand from China, Japan, and India.

Major Points Covered in Table of Contents:1 Executive Summary2 Methodology And Market Scope3 Infiniband Market Industry Outlook4 Biochemistry Analyzer Market Type Outlook5 Biochemistry Analyzer Market Application Outlook6 Biochemistry Analyzer Market Regional Outlook7 Competitive Landscape

Customization Service of the Report:

Orian Research provides customisation of reports as per your need. This report can be personalised to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

Orian Researchis one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner RelationsOrian Research ConsultantsUS: +1 (832) 380-8827 | UK: +44 0161-818-8027Email:[emailprotected]

Website:www.orianresearch.com/

Follow this link:
COVID-19 Impact on Global Biochemistry Analyzer Industry 2020: Industry Trends, Size, Applications, SWOT Analysis by Top Key Players and Forecast...

NMSU’s Breland Hall evolves over more than 60 years – New Mexico State University NewsCenter

Facebook Twitter LinkedIn Google+ Pinterest

Built in 1956, Breland Hall, named after Rufus Galloway Breland, is home to the College of Arts and Sciences, which includes 26 departments. Originally built as mens dormitories, Breland Hall accommodated 300 men and offered modern facilities such as a television and recreational lounge along with laundry facilities. Breland Hall served as a dorm for two decades before being repurposed into an academic building for the College of Arts and Sciences, which provides the core liberal arts education at NMSU. The departments for humanities and social sciences are mainly located at Breland Hall along with the offices of the dean, while other areas such as astronomy, biology, geology, chemistry and biochemistry are housed in separate facilities on campus with both classrooms and laboratories.

About Rufus Galloway Breland

Rufus Galloway Breland was born in Maryland in December 1906. Breland came to NMSU in 1925 as an English professor. He taught English literature, public speaking, and vocabulary. Although he was a strict professor, he was beloved by his students. After teaching for four years, he served as department head until his death in 1940. In February 1956, the Board of Regents voted to name the new mens dormitory in honor of Rufus Breland. The dormitory was officially dedicated during homecoming in 1958 when Brelands brother from New York City could be there for the ceremony.

Architectural History

Breland Hall was part of the new wave of architecture after the university outgrew architect Henry C. Trosts master plan that was developed in 1907 for thirteen buildings positioned around "The Horseshoe." His plan was followed faithfully until the growth of the school and its programs required expansion beyond the horseshoe.

The architectural style adopted by Trost and McGhee was still utilized to some degree by other architects following World War II and well into the 1950s. Breland Hall was one of the buildings that included Trosts Spanish Renaissance style that featured hipped roofs with clay tiles and domed towers.

Santa Fe architect Leo J. Wolgamood worked as a draftsman under many renowned architects around the world and served in the Civil Engineer Corps of the U.S. Navy before becoming a registered architect in New Mexico where he formed a partnership with Alfred R. Millington in Santa Fe.

In the mid-1950s, Wolgamood designed several school buildings across New Mexico. At NMSU, Wolgamood designed Breland Hall, along with Gardiner Hall and the Chemistry Building. His buildings reflected the trend toward Regional Modernism by incorporating Modernist styling, such as large glass curtain walls at the main entries, with touches of Spanish Renaissance Revival styling, such as red tile roofing, that emulated the work of previous architects Trost and Percey McGhee.

In October of 1952, the Board of Regents applied for $1 million in loan assistance for the construction of Breland Hall and Hamiel Hall. Construction began in 1954 and Breland Hall was completed by September 1, 1956 at a cost of $705,666.

Renovations over the years

Breland Hall has undergone several renovations and improvements over more than 60 years. The most significant project was in 1976 when the facility was remodeled, changing its use from a dormitory to accommodate the College of Arts and Sciences offices, classrooms, and laboratories. The renovation cost $1.9 million.

NMSU History Archives

Read more here:
NMSU's Breland Hall evolves over more than 60 years - New Mexico State University NewsCenter

Meet the maker: EPM talks to CN Bio’s Jean-Pierre Joubert – EPM Magazine

EPM speaks to Jean-Pierre Joubert, product manager at CN Bio Innovations who talks about his journey into biotech, the challenges of drug development, and why opportunities come from unlikely places.Could you give us a brief description of yourself and what you do at CN Bio?

Coming from a microbiology and biochemistry background, with a diverse array of interesting past roles, I have a unique perspective and approach in what I do. My previous roles include genomics product manager for a large multinational company, marketing manager, product manager for a microbiological biotechnology start-up, overseeing customer relations and sales, as well as being the laboratory manager for one of the largest aquariums in the southern hemisphere!

As a product manager at CN Bio Innovations, a market-leading organ-on-chip biotech company, I am tasked with ensuring the successful launch of my product, managing the lifecycle to ascertain a driving position within the global drug development market.

Teamwork. Intriguing.Dynamic. Coordination. Research.

Upon moving to the UK from South Africa in 2016, where I was a laboratory manager in a large public aquarium, I entered the biotech field. My first product manager role was launching market-disruptive equipment related to microbiological testing (perfect with my background in microbiology and biochemistry). This linked very closely with the pharma market, and subsequent roles kept this association as a genomics product manager and now as a product manager at CN Bio Innovations, working with equipment centred within the pharma and biotechnology spectrum.

It is going to sound clichd, but every time I bring a new product to market, it is a new career highlight. Being a product ,manager means being involved in every aspect of the product development from inception to launch (and beyond). Seeing something which is a culmination of ideas, proposals, design modifications and user feedback is really a fulfilling experience. I am in the fortunate position of managing products which I truly believe will make a difference making it easy to be passionate about them!

I tend to get involved too easily, agreeing to take on more and more. I think that is why product management suits me so well I am able to be involved in many different facets of the product cycle, though I have had to train myself to delegate and not keep putting my hand up, but rather guide others where needed.

There is so much! I love being involved in bringing new technology, which I really believe will make a difference, to market. Working with diverse teams I get to learn something new every day, which is very important to me and keeps me growing. Being customer-facing is a huge boon to me. I absolutely love interacting with customers and building new relationships the interplay can be quite exhilarating.

And my team at CN Bio (of course). Our company is very close-knit, filled with people at the top of their field working together as a cohesive, caring and informal team!

The one thing I would change is accessibility to market. Organ-on-chip and microfluidic technology is still very unknown, which makes market penetration quite challenging. Though we are making a difference within the industry, I do feel that getting the technology out there and increasing exposure would benefit everyone on all levels of the industry ladder!

Outside of product management, I really enjoy marketing. Having done quite a bit of it throughout my career, it is my second passion.

Resource optimisation. In this time of remote working I think people are going to need to optimise resources such as staff, space and other resources. Combine this with a greater need for medical research and drug development at a greater pace, and you have quite a challenging environment on the horizon. But it is also an exciting frontier which leaves a lot of space for innovation which is why we at CN Bio are constantly working to improve, innovate and push the envelope.

If the Covid-19 crisis has shown us anything, it is that there are opportunities in the most unlikely places.

I think major opportunities lie in drug development and redevelopment. Being able to increase drug development efficiency, to optimise current models or test existing compounds for new applications is the wave that is building hard and fast. The pandemic has also seen companies open more to collaborations, which I feel will be the cornerstone that facilitates the greatest breakthroughs.

We at CN Bio Innovations are already collaborating with a wide variety of partners on this front from academics to some of the worlds biggest pharma companies and regulatory bodies. Being able to bring health solutions to market cheaper and faster benefits the whole world, empowering us all to achieve our full potential.

Original post:
Meet the maker: EPM talks to CN Bio's Jean-Pierre Joubert - EPM Magazine

Biochemistry Analyser Market Registered 5.5% CAGR with the Market Value US$ 4700 Mn in Forecast Year 2024 – WaterCloud News

New York City, United States With the outbreak of COVID-19 in worldwide and stipulated lockdown, the healthcare sector is witnessing an unprecedented slowdown as per EY-FICCI study titled, COVID-19 impact assessment for healthcare sector and key financial measures recommendations for the sector. The study is predicated on an assessment of healthcare players within the country to assess the economic impact of the COVID-19 pandemic and provides recommendations on the fiscal stimulus measures it needs within the coming months.

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. In addition to this, accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe. Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors.

A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/6451

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/6451

Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction.

The report current values the globalbiochemistry analyzer marketat a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.

Key Research Insights from the Report include:

The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024

Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patients metabolic functions

Access Full Report @ https://www.persistencemarketresearch.com/checkout/6451

Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America

Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR

Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers a cost-effective upgrade to existing product line

The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers.

Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR.

The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.

More here:
Biochemistry Analyser Market Registered 5.5% CAGR with the Market Value US$ 4700 Mn in Forecast Year 2024 - WaterCloud News

Rowan junior named a top undergrad researcher in chemistry – Rowan Today

A Rowan University student has received the prestigious Eastern Analytical Symposium Undergraduate Student Research Award for 2020.

Joshua Davis, from Swedesboro, New Jersey, is one of four students nationally recognized for their work in the field of analytical chemistry. Awardees are selected by an independent jury of experts from nominations received from the scientific community at large.

Davis was nominated and selected for his outstanding work developing novel microfluidic devices designed for both point-of-care clinical diagnostics and fundamental studies related to breast cancer metastasis. His efforts have been partially supported through a Restek Academic Support Program grant.

The award selection committee also appreciated Daviss efforts during the COVID-19 pandemic. This spring, he was part of a collaborative team of Rowan University faculty and students that created 3D-printed face masks to address a shortage of personal protective equipment for South Jerseys health care workers and emergency responders.

Davis will receive an honorarium, travel expenses to the November 2020 Eastern Analytical Symposium in Princeton, a plaque, and the opportunity to present his work at the symposium.

Rowan University President Dr. Ali Houshmand praised the College of Science & Mathematics for preparing Davis.

This is truly impressive and a testament to the high level of undergraduate research that takes place in the College, Houshmand said. Congratulations to Josh and the entire Chemistry faculty.

"For two years in a row, the Eastern Analytical Symposium has recognized a Rowan University undergraduate for research excellence, said Dr. Beena Sukumaran, Rowans vice president of research. We are so gratified to know that our students' hard work and dedication in the lab are earning the respect they deserve. Joshua Davis award exemplifies what we value at Rowan, which is the integration of undergraduate students in research."

For the past two years, Davis has been working in the laboratory of Dr. James Grinias, assistant professor in the Department of Chemistry & Biochemistry. His research focuses on how to reduce the size and cost of pumping mechanisms for analytical devices.

Traditional devices are still very large and require samples to be taken in the lab. Davis believes his research on reducing the size of microfluidic devices is important, because it enables chemical and biological analytical costs to be reduced while obtaining results similar to those found with benchtop equipment.

The thing that makes Josh special is his strong work ethic and his relentless dedication to excellence, Grinias said. He works so hard to finish just one more experiment to really make sure that his new microfluidic devices are working properly or to confirm that the data truly answers the questions he is asking.

Davis values the opportunity to do laboratory work as an undergraduate.

To do undergraduate research, in my eyes, is very important because it bridges the gap from fundamentals learned in the classroom to the application of what is being studied, Davis said. It allows you to gain the experience that you will need to solve problems in a job setting or in graduate school.

In turn, Grinias values Davis contributions in the lab.

He is technically gifted and has taught himself many engineering-related skills that we need for our research, that I myself did not possess, said Grinias. His ultimate goal is the success of the project and he will not rest until he achieves it.

In addition to this honor, Davis was named Rowan Universitys Department of Chemistry & Biochemistry winner of the American Chemical Society Undergraduate Award in Analytical Chemistry for 2020.

Davis plans to continue his research during his upcoming senior year at Rowan. After graduation, he plans to pursue graduate studies in analytical chemistry.

His true goal in the pursuit of a career in analytical chemistry is to help others, a trait I truly admire in him, said Grinias.

Davis is the second student from Rowan University to receive this award. Samuel Foster, also a member of the Grinias lab team, won the award in 2019. Foster graduated with a B.S. in Chemistry in May 2020 and will begin his graduate studies in analytical chemistry this fall at Rowan University.

The rest is here:
Rowan junior named a top undergrad researcher in chemistry - Rowan Today

Join Michael Behe for an Online Conversation about Viruses and Evolution – Discovery Institute

In a free online Zoom webinar on Saturday, June 13, biochemist Behe will review the biochemistry of viruses in general and COVID-19 in particular. He will use these topical examples to illustrate a fundamental principle: Darwinian and other unintelligent evolutionary mechanisms can change life marginally, in ways that are medically important, yet they cannot explain lifes complex structure. Rather, the elegant molecular structures of life required purposeful intelligent design.

Join us from 6 pm to 7:30 pm. Registration is required! Find more information and a link to register here. The event is graciously sponsored by the Colorado, Houston, and Southern California ChaptersofDiscovery Institutes Science & Culture Network.

Photo credit: Michael Behe, by Chris Morgan.

See the article here:
Join Michael Behe for an Online Conversation about Viruses and Evolution - Discovery Institute

[PDF] Essential Cell Biology Download Full PDF Book Download

Bruce Alberts,Dennis Bray,Karen Hopkin,Alexander D Johnson,Julian Lewis,Martin Raff,Keith Roberts,Peter Walter 2013-10-15Science

Bruce Alberts,Dennis Bray,Alexander Johnson,Julian Lewis,Peter Walter,Martin Raff,Keith Roberts 1998Science

Bruce Alberts,Karen Hopkin,Alexander D. Johnson,Martin Raff,David Morgan,Keith Roberts,Peter Walter 2018-11-19Science

Alberts,Bruce,Hopkin, Karen,Johnson, Alexander D.,Morgan, David,Raff, Martin,Roberts, Keith,Walter, Peter 2018-11-19Science

Fifth International Student Edition

Bruce Alberts,Dennis Bray,Karen Hopkin,Julian Lewis,Alexander D. Johnson,Martin Raff,Keith Roberts,Peter Walter 2016-06-01

N.A 1997Biochemistry

An Introduction to the Molecular Biology of the Cell

John Davey,Mike Lord,J. Michael Lord 2003-06-05Science

Cell Structure

John Davey,J. Mike Lord 2003Cytology

Excerpt from:
[PDF] Essential Cell Biology Download Full PDF Book Download

Breakthrough discovery could lead to treatment of Fragile X syndrome – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Jun 2 2020

Scientists at the Hotchkiss Brain Institute (HBI), Alberta Children's Hospital Research Institute (ACHRI), and Owerko Centre at UCalgary's Cumming School of Medicine (CSM) have made a breakthrough discovery that could lead to treatment of Fragile X syndrome (FXS), the leading genetic cause of Autism Spectrum Disorder. The study, involving mouse models, shows promise of translating to treatment for people diagnosed with FXS.

FXS causes intellectual disabilities and hyperactive behaviour, usually more commonly seen in males than females. Children and adults with FXS are missing a protein vital to brain development called FMRP. Among other functions, FMRP helps develop synapses between neurons in the brain.

Dr. Raymond W. Turner, PhD, and members of his study team including Drs. Xiaoqin Zhan, PhD, Hadhimulya Asmara, PhD, and Ning Cheng, PhD, made the discovery while studying ion channels in the brain - special proteins that conduct currents through cells, enabling communication within the brain.

If I had to make an analogy, it might be akin to insulin and diabetes. With FXS, individuals are missing this protein - let's try putting it back in. In 30 minutes, the protein distributed throughout the brain, and accomplished what it's supposed to do at the single-cell level."

Dr. Raymond W. Turner, study lead, and professor in the departments of Cell Biology & Anatomy, and Physiology & Pharmacology at the CSM

Unlike injected insulin, which helps someone with diabetes control their blood sugar for a few hours, the FMRP injection helps restore protein levels in the cerebellum and brain for up to one day after the injection. "Hyperactivity was reduced for almost 24 hours," says Zhan, a postdoctoral scholar in the Turner lab. "We did one injection and we tested for it one day later, and three key proteins that are known to be in Fragile X were still at restored normal levels."

In other, unsuccessful attempts to inject mouse models with FMRP to mitigate FXS, scientists used the entire molecule. But Turner and his colleagues used a fragment of FMRP which was able to cross the blood-brain barrier. "It's not a full FMRP molecule at all but rather a fragment with important structural features and functional components that are active in doing things like controlling ion channels or the levels of other proteins," says Cheng, a research associate in the Turner lab.

In the next phase, the researchers will investigate using other parts of the FMRP molecule to mitigate cognitive disorders associated with FXS. "Unlike a lot of drug therapies where you hope you can get your drug to one specific group of cells, FMRP is expressed in just about every cell in the brain, so an all-encompassing wide-based application is what you want," says Turner.

Beyond potential treatments for FXS, the research could help develop treatments to offset behavioural symptoms characteristic of other Autism Spectrum Disorders.

The findings are published in Nature Communications.

Funding for the study was provided by the Canadian Institutes of Health Research (CIHR), Alberta Children's Hospital Foundation through ACHRI, Simons Foundation Autism Research Initiative (SFARI) Explorer grant, and fellowship support from FRAXA and Fragile X Research Foundation of Canada, the HBI and CSM Postdoctoral Fellowship programs.

This technology has a patent through Innovate Calgary, the university's knowledge transfer and business incubator centre, which continues to develop its commercial path through partnership/investment to advance this discovery as a viable treatment for patients.

The Turner lab works on the role of an ion channel complex they discovered that controls multiple functions in the cerebellum that led them to look at the effects of losing FMRP in the knockout mouse model. The reason replacing FMRP was so effective is that it turns out to be part of the very ion channel complex the lab has been studying for 10 years.

Led by the Hotchkiss Brain Institute, Brain and Mental Health is one of six research strategies guiding the University of Calgary toward its Eyes High goals. The strategy provides a unifying direction for brain and mental health research at the university.

Source:

Journal reference:

Zhan, X., et al. (2020) FMRP(1297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome. Nature Communications. doi.org/10.1038/s41467-020-16250-4.

Follow this link:
Breakthrough discovery could lead to treatment of Fragile X syndrome - News-Medical.Net

Texas A&M Researchers Use 3D-Printed Biomaterials Laced With Stem Cells To Create Superior Bone Grafts – Texas A&M University Today

NICE ink developed by Texas A&M researchers can be used to 3D print customizable craniofacial implants.

Courtesy of Akhilesh Gaharwar

Subtle variations in the architecture of the 22 bones of the skull give each one of us a unique facial profile. So repairing the shape of skull defects, in the event of a fracture or a congenital deformity, calls for a technique that can be tailored to an individuals face or head structure.

In a new study, researchers at Texas A&M University have combined 3D printing, biomaterial engineering and stem cell biology to create superior, personalized bone grafts. When implanted at the site of repair, the researchers said these grafts will not only facilitate bone cells to regrow vigorously, but also serve as a sturdy platform for bone regeneration in a desired, custom shape.

Materials used for craniofacial bone implants are either biologically inactive and extremely hard, like titanium, or biologically active and too soft, like biopolymers, said Roland Kaunas, associate professor in the Department of Biomedical Engineering. In our study, we have developed a synthetic polymer that is both bioactive and mechanically strong. These materials are also 3D printable, allowing custom-shaped craniofacial implants to be made that are both aesthetically pleasing and functional.

A detailed report on the findings was published online in the journalAdvanced Healthcare Materialsin March.

Each year, about 200,000 injuries occur to bones of the jaw, face and head. For repair, physicians often hold these broken bones in place using titanium plates and screws so that surrounding bone cells can grow and form a cover around the metal implant. Despite its overall success in aiding bone repair, one of the major drawbacks of titanium is that it does not always integrate into bone tissue, which can then cause the implant to fail, requiring another surgery in advanced cases.

Thus, biocompatible polymers, particularly a type called hydrogels, offer a preferable alternative to metal implants. These squishy materials can be loaded with bone stems cells and then 3D printed to any desired shape. Also, unlike titanium plates, the body can degrade hydrogels over time. However, hydrogels also have a known weakness.

Although the pliability of hydrogel-based materials makes them good inks for 3D bioprinting, their softness compromises the mechanical integrity of the implant and the accuracy of printed parts, said Akhilesh Gaharwar, associate professor in the Department of Biomedical Engineering.

To increase the stiffness of the hydrogel, the researchers developed a nanoengineered ionic-covalent entanglement or NICE recipe containing just three main ingredients: an extract from seaweed called kappa carrageenan, gelatin and nanosilicate particles that both stimulate bone growth and mechanically reinforce the NICE hydrogel.

First, they uniformly mixed the gelatin and kappa carrageenan at microscopic scales and then added the nanosilicates. Gaharwar said the chemical bonds between these three items created a much stiffer hydrogel for 3D bioprinting with an almost eight-fold increase in strength compared to individual components of NICE bioink.

Next, they added adult stem cells to 3D parts printed with NICE ink and then chemically induced the stem cells to convert into bone cells. Within a couple of weeks, the researchers found that the cells had grown in numbers, producing high levels of bone-associated proteins, minerals and other molecules. In aggregate, these cell secretions formed a scaffold, known as an extracellular matrix, with a unique composition of biological materials needed for the growth and survival of developing bone cells.

When the scaffolds are fully developed, the researchers noted that the bone cells could be removed from the scaffold and the hydrogel-based implant can then be inserted into the site of skull injury where the surrounding, healthy bones initiate healing.Over time, the 3D printed scaffolds biodegrade, leaving behind a healed bone in the right shape.

The idea is to have the bodys own bone repair machinery participate in the repair process, Kaunas said. Our biomaterial is enriched with this regenerative extracellular matrix, providing a fertile environment to naturally trigger bone and tissue restoration.

The researchers said that the 3D-printed scaffolds provide a strong structural framework that facilitates the attachment and growth of healthy bone cells. Also, they found that developing bone cells penetrate through the synthetic material, thereby increasing the functionality of the implant.

Although our current work is focused on repairing skull bones, in the near future, we would like to expand this technology for not just craniomaxillofacial defects but also bone regeneration in cases of spinal fusions and other injuries, Kaunas said.

Other contributors to this study include Candice Sears, Eli Mondragon, Zachary Richards, Nick Sears and David Chimene from the Texas A&M Department of Biomedical Engineering; and Eoin McNeill and Carl A. Gregory from the Texas A&M Health Science Center.

This research is funded by the National Institutes of Health and the National Science Foundation.

Here is the original post:
Texas A&M Researchers Use 3D-Printed Biomaterials Laced With Stem Cells To Create Superior Bone Grafts - Texas A&M University Today